Several miRNAs are known to be aberrantly expressed in human BC tissue and have been correlated with clinical stage and clinico-pathological variables like hormone receptor status, tumor subtypes, as well as clinical variables like metastatic potential, progression free survival and overall survival [19], [61]–[65]. This evidence concerns the gene NR4A1 and neoplasm.